Cargando…
Clozapine administration enhanced functional recovery after cuprizone demyelination
The atypical antipsychotic agent, clozapine, is used to treat a variety of neurological disorders including schizophrenia and Parkinson’s disease and readily crosses the blood brain barrier to interact with a wide range of neuroreceptors including those for dopamine and serotonin. Recent work has sh...
Autores principales: | Templeton, Nikki, Kivell, Bronwyn, McCaughey-Chapman, Amy, Connor, Bronwen, La Flamme, Anne Camille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6508663/ https://www.ncbi.nlm.nih.gov/pubmed/31071102 http://dx.doi.org/10.1371/journal.pone.0216113 |
Ejemplares similares
-
Sex Differences in the Behavioural Aspects of the Cuprizone-Induced Demyelination Model in Mice
por: Paton, Kelly F., et al.
Publicado: (2022) -
Enhanced disease reduction using clozapine, an atypical antipsychotic agent, and glatiramer acetate combination therapy in experimental autoimmune encephalomyelitis
por: Green, Laura K, et al.
Publicado: (2017) -
Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease
por: Denny, Lisa, et al.
Publicado: (2021) -
Amelioration of experimental autoimmune encephalomyelitis by clozapine is not associated with defective CD4 T cell responses
por: Zareie, Pirooz, et al.
Publicado: (2017) -
Clozapine reduces infiltration into the CNS by targeting migration in experimental autoimmune encephalomyelitis
por: Robichon, Katharina, et al.
Publicado: (2020)